Related Experiment Video
Updated: Oct 11, 2025
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
Precision biomaterials in cancer theranostics and modelling
David Caballero1, Catarina M Abreu1, Ana C Lima1
13B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barco, 4805-017, Guimarães, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga, Guimarães, Portugal.
Precision biomaterials offer a revolutionary approach to cancer management, improving detection, modeling, and treatment efficacy. These advanced materials are engineered for personalized cancer care, overcoming limitations of traditional therapies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Material Science
Background:
- Traditional cancer treatments face limitations due to a 'one-size-fits-all' approach, leading to treatment failures.
- Personalized medicine shows promise but struggles with systemic delivery issues like low local efficacy.
- Precision medicine strategies are crucial for enhancing cancer theranostics and modeling.
Purpose of the Study:
- To review the latest advances in precision biomaterials for cancer research.
- To highlight the potential of precision biomaterials in revolutionizing cancer management.
- To discuss applications in cancer modeling, detection, and therapy.
Main Methods:
- Review of current literature on precision biomaterials in cancer research.
- Analysis of interdisciplinary research convergence (biomedicine, material sciences, etc.).
- Focus on engineered biomaterials with specific theranostic functions and bioactive components.
Main Results:
- Precision biomaterials offer tailored solutions for individual patient needs.
- These materials show significant potential for more accurate, localized, and efficient cancer detection and treatment.
- Advancements are paving the way for improved cancer modeling and theranostics.
Conclusions:
- Precision biomaterials represent a significant advancement in precision oncology.
- Further development and clinical translation are needed to accelerate their application.
- These materials are poised to improve cancer patient prognosis and revolutionize disease management.
